Literature DB >> 20419335

The diagnostic yield of D-Dimer in relation to time from symptom onset in patients evaluated for venous thromboembolism in the emergency medicine department.

Yelena Goldin1, Oren Pasvolsky, Ori Rogowski, Itzhak Shapira, Arie Steinvil, Pinchas Halpern, Jack Serov, Varda Deutsch, Galit Aviram, Shlomo Berliner.   

Abstract

D-Dimer concentrations increase following the thrombotic event and decrease thereafter. Timing of D-Dimer evaluation in relation to the onset of the disease might have a diagnostic impact. We have presently performed a retrospective analysis of diagnostic procedures performed in individuals who presented to the Emergency department and evaluated for acute venous thromboembolism (VTE) following a single quantitative D-Dimer testing. Individuals who had a negative objective test served as controls to those who had a positive one (Doppler ultrasonography, high probability lung scan or a CT angiography). Seven hundred thirty-four individuals presented to the Emergency department, performed a single D-Dimer test as well as an objective test during their evaluation for an eventual event of acute VTE. One hundred ninety-seven patients had a positive objective test for either deep vein thrombosis (DVT) or pulmonary embolus. They were divided into seven tiles of times from symptoms onset. Highly significant differences between patients and controls regarding D-Dimer concentrations were noted mainly during the early days from symptom onset and turned less significant thereafter. Taking into consideration the time from symptoms onset in patients with acute VTE might have an effect on the diagnostic yield of quantitative D-Dimer in the Emergency department. We suggest not to exclude the eventual presence of acute VTE if quantitative D-Dimer is obtained later than 1 week following the onset of symptoms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20419335     DOI: 10.1007/s11239-010-0480-6

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  10 in total

1.  The early course of D-dimer concentration following pulmonary artery embolisation.

Authors:  J J Mager; R E Schutgens; F J Haas; C J Westermann; D H Biesma
Journal:  Thromb Haemost       Date:  2001-12       Impact factor: 5.249

Review 2.  Management studies using a combination of D-dimer test result and clinical probability to rule out venous thromboembolism: a systematic review.

Authors:  A J Ten Cate-Hoek; M H Prins
Journal:  J Thromb Haemost       Date:  2005-09-09       Impact factor: 5.824

3.  D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis.

Authors:  Benilde Cosmi; Cristina Legnani; Michela Cini; Giuliana Guazzaloca; Gualtiero Palareti
Journal:  Thromb Haemost       Date:  2005-11       Impact factor: 5.249

4.  D-dimer determination to assess regression of deep venous thrombosis.

Authors:  M C Janssen; H Verbruggen; H Wollersheim; B Hoogkamer; H van Langen; I R Nováková
Journal:  Thromb Haemost       Date:  1997-08       Impact factor: 5.249

5.  Determinants of plasma fibrin D-dimer sensitivity for acute pulmonary embolism as defined by pulmonary angiography.

Authors:  J A Heit; T A Minor; J C Andrews; D R Larson; H Li; W L Nichols
Journal:  Arch Pathol Lab Med       Date:  1999-03       Impact factor: 5.534

6.  D-dimer and TAT measurement in patients with deep venous thrombosis: utility in diagnosis and judgement of anticoagulant treatment effectiveness.

Authors:  W Speiser; R Mallek; R Koppensteiner; A Stümpflen; S Kapiotis; E Minar; H Ehringer; K Lechner
Journal:  Thromb Haemost       Date:  1990-10-22       Impact factor: 5.249

7.  D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism.

Authors:  S Shrivastava; P M Ridker; R J Glynn; S Z Goldhaber; S Moll; H Bounameaux; K A Bauer; C M Kessler; M Cushman
Journal:  J Thromb Haemost       Date:  2006-06       Impact factor: 5.824

8.  Elevated levels of soluble fibrin or D-dimer indicate high risk of thrombosis.

Authors:  H Wada; T Kobayashi; Y Abe; T Hatada; N Yamada; A Sudo; A Uchida; T Nobori
Journal:  J Thromb Haemost       Date:  2006-06       Impact factor: 5.824

9.  Markers of hemostatic system activation in acute deep venous thrombosis-evolution during the first days of heparin treatment. The DVTENOX Study Group.

Authors: 
Journal:  Thromb Haemost       Date:  1993-12-20       Impact factor: 5.249

10.  Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC).

Authors:  Adam Torbicki; Arnaud Perrier; Stavros Konstantinides; Giancarlo Agnelli; Nazzareno Galiè; Piotr Pruszczyk; Frank Bengel; Adrian J B Brady; Daniel Ferreira; Uwe Janssens; Walter Klepetko; Eckhard Mayer; Martine Remy-Jardin; Jean-Pierre Bassand
Journal:  Eur Heart J       Date:  2008-08-30       Impact factor: 29.983

  10 in total
  7 in total

1.  The value of plasma D-dimer level on admission in predicting no-reflow after primary percutaneous coronary intervention and long-term prognosis in patients with acute ST segment elevation myocardial infarction.

Authors:  Ayhan Erkol; Vecih Oduncu; Burak Turan; Alev Kılıçgedik; Dicle Sırma; Gökhan Gözübüyük; Can Yücel Karabay; Ahmet Guler; Cihan Dündar; Kürşat Tigen; Selçuk Pala; Cevat Kırma
Journal:  J Thromb Thrombolysis       Date:  2014-10       Impact factor: 2.300

2.  Emergency Physician Performed Ultrasound for DVT Evaluation.

Authors:  John Christian Fox; Kiah Christine Bertoglio
Journal:  Thrombosis       Date:  2011-03-06

3.  Clinical Characteristics and Predictors of Mortality in Minority Patients Hospitalized with COVID-19 Infection.

Authors:  Rizwan Muhammad; Richard Ogunti; Alicia N Thomas; Alem Mehari; Basharat Ahmad; Muhammad Munawar; Sahai Donaldson; Mahbubur Sumon; Angesom Kibreab
Journal:  J Racial Ethn Health Disparities       Date:  2021-02-04

4.  Diagnostic Delay of Pulmonary Embolism in COVID-19 Patients.

Authors:  Federica Melazzini; Margherita Reduzzi; Silvana Quaglini; Federica Fumoso; Marco Vincenzo Lenti; Antonio Di Sabatino
Journal:  Front Med (Lausanne)       Date:  2021-04-30

5.  A Case of COVID-19-Associated Free-Floating Aortic Thrombus Successfully Treated with Thrombectomy.

Authors:  Lisa Dao; Alina Lund; Christina D Schibler; Christine A Yoshioka; Maria Barsky
Journal:  Am J Case Rep       Date:  2021-11-25

6.  Predictive value of N-terminal pro-B-type natriuretic peptide (NT-pro BNP) combined with D-dimer for no-reflow phenomenon in patients with acute coronary syndrome after emergency of percutaneous coronary intervention.

Authors:  Yujing Diao; Meifeng Yin; Baoguo Zhang; Bin Sun
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 7.  Effectiveness of d-dimer as a screening test for venous thromboembolism: an update.

Authors:  Swaroopa Pulivarthi; Murali Krishna Gurram
Journal:  N Am J Med Sci       Date:  2014-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.